Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 7 min ago
PreprintAll rights reservedbioRxiv

Collateral Immune Cell Signaling Compromises the Efficacy of T-cell Engaging Therapies for Cardiac Fibrosis

  • S. Yang
  • A. Parvathaneni
  • Y.-L. Pai
  • A. Koenig
  • F. Kadyrov
  • M. C. Owen
  • J. M. Amrute
  • A. Bredemeyer
  • Y.-S. Hsu
  • A. Kovacs
  • C. J. Weinheimer
  • J. M. Nigro
20 more authors
  • L. Yeh
  • T. Williamson
  • J. G. Rurik
  • M. Thomas
  • J. Wang
  • S. Mandavalli
  • K. Cook
  • T. Yamawaki
  • S. Das
  • N. Hartmann
  • L. M. Wienecke
  • C. Baker
  • C.-M. Li
  • F. Leuschner
  • N. Rosenthal
  • J. A. Epstein
  • N. Singh
  • S. Jackson
  • B. Ason
  • K. Lavine1
  1. 1Washington University School of Medicine
Read full textPDFDOICite

Related

  1. BUB signaling in cancer and molecular insights into targeted therapies
    Bhavika Baweja, Chainsee Saini, Prerna Vats +5
    Communications BiologyPeer-reviewedCC BY 4.0Full textCell biologyCrossref
  2. Comparative efficacy and safety of systemic therapies for moderate-to-severe atopic dermatitis in adults: a systematic review of randomized controlled trials
    Vasiliki Pikoula, Efterpi Zafiriou, Anthony Bewley +12
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  3. Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update.
    Jeanne Jiang, Abigail Wojtowicz, Jennifer Uyei +3
    BMC gastroenterologyPeer-reviewedCC BY-NC-NDFull textGenetics & genomicsEurope PMCDOAJ
  4. A signaling-optimized TIGIT chimeric switch receptor promotes metabolic fitness and antitumor efficacy of TCR/CAR T cells
    E. Antunes Ferreira, K. J. Legscha, U. R. Schmits +3
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  5. How Periodontal Disease Compromises Oral Functions Related to Ingestion: Evidence From Systematic Review and Meta‐Analysis
    Thomas Douillard, Martine Hennequin, Emmanuel Nicolas +1
    Journal of Oral RehabilitationPeer-reviewedLicence not statedFull textGeneral biologyHAL

Cite

BibTeXRIS
BibTeX
@misc{yang2026collateral,
  title = {{Collateral Immune Cell Signaling Compromises the Efficacy of T-cell Engaging Therapies for Cardiac Fibrosis}},
  author = {S. Yang and A. Parvathaneni and Y.-L. Pai and A. Koenig and F. Kadyrov and M. C. Owen and J. M. Amrute and A. Bredemeyer and Y.-S. Hsu and A. Kovacs and C. J. Weinheimer and J. M. Nigro and L. Yeh and T. Williamson and J. G. Rurik and M. Thomas and J. Wang and S. Mandavalli and K. Cook and T. Yamawaki and S. Das and N. Hartmann and L. M. Wienecke and C. Baker and C.-M. Li and F. Leuschner and N. Rosenthal and J. A. Epstein and N. Singh and S. Jackson and B. Ason and K. Lavine},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.15.751626},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.15.751626v1},
}
RIS
TY  - UNPB
TI  - Collateral Immune Cell Signaling Compromises the Efficacy of T-cell Engaging Therapies for Cardiac Fibrosis
AU  - S. Yang
AU  - A. Parvathaneni
AU  - Y.-L. Pai
AU  - A. Koenig
AU  - F. Kadyrov
AU  - M. C. Owen
AU  - J. M. Amrute
AU  - A. Bredemeyer
AU  - Y.-S. Hsu
AU  - A. Kovacs
AU  - C. J. Weinheimer
AU  - J. M. Nigro
AU  - L. Yeh
AU  - T. Williamson
AU  - J. G. Rurik
AU  - M. Thomas
AU  - J. Wang
AU  - S. Mandavalli
AU  - K. Cook
AU  - T. Yamawaki
AU  - S. Das
AU  - N. Hartmann
AU  - L. M. Wienecke
AU  - C. Baker
AU  - C.-M. Li
AU  - F. Leuschner
AU  - N. Rosenthal
AU  - J. A. Epstein
AU  - N. Singh
AU  - S. Jackson
AU  - B. Ason
AU  - K. Lavine
PY  - 2026
DA  - 2026/09/15
PB  - bioRxiv
DO  - 10.64898/2026.09.15.751626
UR  - https://www.biorxiv.org/content/10.64898/2026.09.15.751626v1
ER  -